Skip to main content

Mouse HVEM/TNFRSF14 Antibody

Bio-Techne includes R&D Systems | Catalog # AF2516

Catalog #
Availability
Size / Price
Qty
Loading...
AF2516
AF2516-SP

Key Product Details

Species Reactivity

Validated:

Mouse

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG

Product Summary for Mouse HVEM/TNFRSF14 Antibody

Immunogen

Mouse myeloma cell line NS0-derived recombinant mouse HVEM/TNFRSF14
Gln39-Val207
Accession # NP_849262

Specificity

Detects mouse HVEM/TNFRSF14 in direct ELISAs and Western blots. In direct ELISAs, approximately 100% cross-reactivity with recombinant rat HVEM/TNFRSF14 is observed, and less than 5% cross-reactivity with recombinant human (rh) HVEM is observed and less than 2% cross-reactivity with recombinant mouse (rm) DR3, rmFas, rmGITR, rmTWEAK R, rm4‑1BB, rmBAFF R, rmCD27, rmCD30, rmCD40, rmEDAR, rmNGF R, rmOX40, rmRANK, rmTNF RI, rmTNF RII, rhDR6, rhTRAIL R3, and rhTRAIL R4 is observed.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Applications for Mouse HVEM/TNFRSF14 Antibody

Application
Recommended Usage

Western Blot

0.1 µg/mL
Sample: Recombinant Mouse HVEM/TNFRSF14 Fc Chimera (Catalog # 2516-HV)
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Published Applications

Read 1 publication using AF2516 in the following applications:

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: HVEM/TNFRSF14

HVEM (herpesvirus entry mediator) is a type I membrane protein that is TNF receptor superfamily member 14 (TNFRSF14) (1). The mouse HVEM cDNA encodes a 275 amino acid (aa) protein. It contains a 36 aa signal peptide, a 170 aa extracellular domain with three cysteine rich domains (CRD), a 24 aa transmembrane region and a 45 aa cytoplasmic tail with a TRAF interaction domain (1). HVEM expression is highest on naïve, memory and regulatory T cells, but declines during T cell activation (2, 3). It is present at low levels on most resting leukocytes (4). HVEM is a receptor for the IGSF member BTLA (B and T lymphocyte attenuator), CD160, and the TNF family ligand LIGHT (lymphotoxins, exhibits inducible expression, and competes with HSV glycoprotein D for HVEM, a receptor expressed by T lymphocytes) (2, 9). HVEM and BTLA are constitutively expressed on T cells, while LIGHT is generally considered to be inducible upon TCR activation. In the absence of activation, HVEM and BTLA interact monomerically, either in cis, or in trans. A same cell (or cis) interaction likely promotes general cell survival, while a between cell (or trans) interaction promotes a state of lymphocyte inactivity through the BTLA cytoplasmic domain. Following T cell activation, LIGHT appears and disrupts existing HVEM-BTLA bonds. A LIGHT-HVEM trimer now forms in trans, initiating HVEM-mediated NF kappaB signaling and a proinflammatory response (10). BTLA and LIGHT interactions are not mutually exclusive, but BTLA appears dominant (4, 6, 7). The herpesvirus envelope glycoprotein gD, which binds HVEM CRD1 to initiate membrane fusion, can antagonize both BTLA and LIGHT binding (1, 6, 7, 9). Human, but not mouse, HVEM can also bind lymphotoxin a within CRD2 3 (9, 11). Graft‑vs‑host disease and Th1 type intestinal inflammation can be ameliorated by interrupting T cell LIGHT/HVEM interactions, while disruption of BTLA/HVEM interaction promotes intestinal inflammation (12-14). Mouse HVEM ECD shares 89% and 53% aa identity with rat and human HVEM, respectively. Mouse HVEM can recognize human BTLA and LIGHT, but human HVEM does not recognize mouse ligands (2, 11).

References

  1. Hsu, H. et al. (1997) J. Biol. Chem. 272:13471.
  2. Sedy, J.R. et al. (2005) Nat. Immunol. 6:90.
  3. Tao, R. et al. (2008) J. Immunol. 180:6649.
  4. Wang, Y. et al. (2005) J. Clin. Invest. 115:711.
  5. Nelson, C.A. et al. (2008) J. Immunol. 180:940.
  6. Gonzales, L.C. et al. (2005) Proc. Natl. Acad Sci. USA 102:1116.
  7. Compaan, D.M. et al. (2005) J. Biol. Chem. 280:39553.
  8. Cai, G. et al. (2008) Nat. Immunol. 9:176.
  9. Mauri, D.N. et al. (1998) Immunity 8:21.
  10. Ware, C.F. (2008) Immunol. Rev. 223:186.
  11. Bossen, C. et al. (2006) J. Biol. Chem. 281:13964.
  12. Xu, Y. et al. (2007) Blood 109:4097.
  13. Wang, J. et al. (2005) J. Immunol. 174:8173.
  14. Steinberg, M.W. et al. (2008) J. Exp. Med. 205:1463.

Long Name

Herpesvirus Entry Mediator

Alternate Names

ATAR, CD270, LIGHTR, TNFRSF14

Entrez Gene IDs

8764 (Human); 230979 (Mouse); 102137807 (Cynomolgus Monkey)

Gene Symbol

TNFRSF14

Additional HVEM/TNFRSF14 Products

Product Documents for Mouse HVEM/TNFRSF14 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Mouse HVEM/TNFRSF14 Antibody

For research use only

Loading...
Loading...
Loading...
Loading...